People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neurona Therapeutics, Inc | — | Biotechnology | Series D+ | $347.5M | $874.2M | 2021 |
| Arvinas, Inc. | — | Biotechnology | Series C | $129.1M | $1.3B | 2015 |
Brad Margus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brad Margus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 1 | 17 |
| David Goeddel | 1 | 10 |
| Kush Parmar | 1 | 10 |
| Tim Shannon | 1 | 9 |
| Stephen Squinto | 1 | 8 |
| Tim Kutzkey | 1 | 7 |
| Sean Cassidy | 1 | 7 |
| Peter Svennilson | 1 | 4 |
| Liam Ratcliffe | 1 | 4 |
| Leo - Guthart | 1 | 4 |
| Jonathan Soderstrom | 1 | 3 |
| Erica Whittaker | 1 | 3 |
| Robert Tjian | 1 | 3 |
| John G. Houston | 1 | 2 |
| Liam D. Ratcliffe | 1 | 2 |
| James Stutz | 1 | 2 |
| Manuel Litchman | 1 | 1 |
| Erica Whitaker | 1 | 1 |
| Ray Kelleher | 1 | 1 |
| Cory Nicholas | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.